首页 › 尿路上皮(移行细胞)癌 › 得克萨斯州 › San Antonio
San Antonio TX 尿路上皮(移行细胞)癌临床试验
11项针对 尿路上皮(移行细胞)癌的研究正在 San Antonio及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
DBC-664 in Adult Patients With Solid Tumors
招募中1 期
- START San Antonio, San Antonio
A Study of GEN1106 in Participants With Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- START - San Antonio, San Antonio
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
招募中3 期
- USA Operation d/b/a US Clinical Trials, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
招募中1 期
- START San Antonio, San Antonio
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
招募中1 期
- NEXT Oncology, San Antonio, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
招募中1/2 期
- Clinical Trial Site, San Antonio
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
招募中1/2 期
- Next Oncology-Oncology, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, San Antonio
其他城市的 尿路上皮(移行细胞)癌试验
- Nashville, TN23 项研究
- New York City, NY22 项研究
- Houston, TX19 项研究
- Dallas, TX18 项研究
- Edison, NJ18 项研究
- Los Angeles, CA17 项研究
- Queens, NY15 项研究
- Chicago, IL14 项研究
- Arlington, VA12 项研究
- Boston, MA11 项研究
- Austin, TX10 项研究
- Orange, CA10 项研究
San Antonio的其他研究
- 非小细胞肺癌59 项研究
- 乳腺癌47 项研究
- 结直肠癌46 项研究
- 转移性癌症44 项研究
- 癌症(所有类型)41 项研究
- 肥胖症40 项研究
- 2型糖尿病37 项研究
- 超重34 项研究
- 卵巢癌31 项研究
- 胰腺癌31 项研究
- 前列腺癌28 项研究
- 子宫内膜癌27 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。